Physician profile
Richard E Ioffreda
NPI 1780752964
$4,278.05
in general payments reported to CMS, 2019-2025
27 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $172 · 2021: $442 · 2022: $608 · 2023: $964 · 2024: $754 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,213 · Education: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,213.46 |
| Education | $561.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,079.98 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $452.77 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $449.60 | 2019-2024 | Xiaflex, Aveed |
| Tolmar, INC. | $302.02 | 2023-2025 | Eligard |
| Janssen Biotech, INC. | $300.82 | 2019-2025 | Erleada |
| Abbvie INC. | $279.15 | 2021-2025 | |
| Pfizer INC. | $218.52 | 2019-2025 | |
| 180 Medical, INC. | $183.34 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $149.31 | 2025 | |
| Myovant Sciences INC. | $113.77 | 2021-2022 | |
| Endo USA, INC. | $98.35 | 2024-2025 | Xiaflex, Aveed |
| Tolmar Pharmaceuticals, INC. | $83.30 | 2021 | |
| Urovant Sciences INC | $82.20 | 2021-2022 | |
| Urogen Pharma, INC. | $64.63 | 2023-2025 | Jelmyto |
| Procept Biorobotics Corporation | $58.36 | 2019-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $55.68 | 2024-2025 | Adstiladrin |
| Boston Scientific Corporation | $38.56 | 2022-2024 | Ams 700 |
| Accord Healthcare, INC. | $36.67 | 2022-2025 | |
| Olympus America INC. | $36.24 | 2025 | Itind System |
| Clarus Therapeutics INC. | $34.83 | 2021 | |
| Abc Home Medical Supply, INC. | $31.99 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $31.78 | 2023 | Bard Urinary Drainage Bag |
| Royal Biologics, INC. | $21.40 | 2020 | |
| Neotract INC. | $20.48 | 2020 | |
| Bioprotect Medical, INC. | $20.35 | 2025 | Bioprotect Balloon Implant System |
| Convatec INC. | $18.99 | 2024 | |
| Teleflex LLC | $14.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ioffreda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.